Clinical Trial Update: Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on early intermittent intensive insulin therapy for Type 2 diabetes, indicating completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED